STIFEL FINANCIAL CORP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$4,545,290
+3.7%
293,813
+5.3%
0.01%0.0%
Q2 2023$4,383,853
-3.3%
279,047
+1.4%
0.01%
-14.3%
Q1 2023$4,535,116
+156.7%
275,188
+143.0%
0.01%
+133.3%
Q4 2022$1,767,006
+10.2%
113,269
-8.4%
0.00%0.0%
Q3 2022$1,604,000
+5.3%
123,697
+14.0%
0.00%
+50.0%
Q2 2022$1,523,000
+10.9%
108,515
+13.2%
0.00%0.0%
Q1 2022$1,373,000
+15.9%
95,836
+10.2%
0.00%0.0%
Q4 2021$1,185,000
-5.7%
86,952
+13.3%
0.00%0.0%
Q3 2021$1,257,000
+15.7%
76,740
+18.9%
0.00%0.0%
Q2 2021$1,086,000
-7.3%
64,562
+0.6%
0.00%0.0%
Q1 2021$1,172,000
-59.1%
64,179
-59.2%
0.00%
-60.0%
Q4 2020$2,863,000
-20.0%
157,304
-21.5%
0.01%
-28.6%
Q3 2020$3,577,000
-2.5%
200,489
-2.0%
0.01%
-12.5%
Q2 2020$3,668,000
+10.5%
204,606
-6.4%
0.01%
-11.1%
Q1 2020$3,320,000
-22.0%
218,665
+1.3%
0.01%0.0%
Q4 2019$4,255,000
+30.1%
215,814
+13.5%
0.01%
+12.5%
Q3 2019$3,271,000
-11.2%
190,165
-8.6%
0.01%
-11.1%
Q2 2019$3,683,000
-10.1%
208,056
+3.2%
0.01%
-25.0%
Q1 2019$4,097,000201,5180.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders